The study's lead author told Newsweek the team found a benefit that reaches past what GLP-1 drugs are usually known for.
Recap by typeshit. Full story at Newsweek on MSN.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
A video walks through retatrutide and how targeting GIP and glucagon alongside GLP-1 sets it apart from current drugs.
A short rundown of how retatrutide is built to act on GLP-1, GIP and glucagon receptors, and what those pathways may affect, like appetite and blood sugar.
Loading…